5 articles suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Authors: Alison M. Schram et al.
Intrinsic electrical activity drives small-cell lung cancer progression
Authors: Paola Peinado et al.
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Authors: Xiaowen Xie et al.
Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay
Authors: Jose L. Montoya Mira et al.
Authors: Shun Zeng et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023